EX-12.1 2 ex12_112312015htm.htm EXHIBIT 12.1 RATIO
Exhibit 12.1
 
Progenics Pharmaceuticals, Inc.
Ratio of (Loss) Earnings to Combined Fixed Charges and Preferred Stock Dividends
(in thousands)
 
 
  
Years Ended December 31,
  
 
  
2015
    
2014
    
2013
    
2012
    
2011
  
Determination of (loss) earnings:
  
   
   
   
   
 
(Loss) income from operations
  
$
(39,119
)
  
$
4,410
 
  
$
(42,934
 )   
$
(35,431
)
  
$
10,381
 
Add:
                                        
Fixed charges
    
373
      
373
      
710
      
410
      
695
  
 
                                        
(Loss) earnings, as adjusted
  
$
(38,746
)
  
$
4,783
 
  
$
(42,224
 )   
$
(35,021
)
  
$
11,076
 
 
                                        
Fixed charges:
                                        
 
                                        
Estimate of interest within rental expense
    
373
      
373
      
710
      
410
      
695
  
 
                                        
Fixed charges
  
$
373
    
$
373
    
$
710
    
$
410
    
$
695
  
 
                                        
Preferred stock dividends
  
$
-
    
$
-
    
$
-
    
$
-
    
$
-
  
 
                                        
Ratio of (loss) earnings to fixed charges and preferred stock dividends
    
*
      
13
      
*
      
*
      
16
  
Coverage deficiency amount for total fixed charges and preferred stock dividends (1)
  
$
39,119
    
$
-
    
$
42,934
    
$
35,431
    
$
-
  

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1)
For the years ended 2012, 2013 and 2015, the Company's coverage ratio is less than one-to-one and it must generate additional earnings of these specified amounts to achieve a coverage ratio of 1:1.